BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22959745)

  • 61. Phenotypes of adults with Fanconi anaemia.
    Wang YM; Loveless M; Miller E; Nelson AS; Mehta PA; Davies SM; Myers KC
    Br J Haematol; 2023 Apr; 201(1):133-139. PubMed ID: 36513378
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fanconi anaemia in South Africa: Past, present and future.
    Feben C; Wainstein T; Kromberg J; Essop F; Krause A
    S Afr Med J; 2018 Apr; 108(5):393-398. PubMed ID: 29843852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fanconi anemia and hematopoietic stem cell transplant as risk factors for oral squamous cell carcinoma: A case report with a 12-year follow-up.
    Macedo LFDSL; Domaneschi C; Miguita Luiz L; Peres MPSM; Franco JB
    Spec Care Dentist; 2022 May; 42(3):299-303. PubMed ID: 34735020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia.
    AmenĂ¡bar JM; Torres-Pereira CC; Tang KD; Punyadeera C
    Cancer; 2019 Nov; 125(22):3936-3946. PubMed ID: 31390058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of clonal diversity and mosaicism on haematopoietic function in Fanconi anaemia.
    Hughes AD; Kurre P
    Br J Haematol; 2022 Jan; 196(2):274-287. PubMed ID: 34258754
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.
    Petryk A; Kanakatti Shankar R; Giri N; Hollenberg AN; Rutter MM; Nathan B; Lodish M; Alter BP; Stratakis CA; Rose SR
    J Clin Endocrinol Metab; 2015 Mar; 100(3):803-11. PubMed ID: 25575015
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modern management of Fanconi anemia.
    Dufour C; Pierri F
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):649-657. PubMed ID: 36485157
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation.
    Beddok A; Krieger S; Castera L; Stoppa-Lyonnet D; Thariat J
    Oral Oncol; 2020 Sep; 108():104816. PubMed ID: 32480311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and cytogenetic profile of Fanconi anemia diagnosed after implementation of mitomycin C cytogenetic test in the state of Pernambuco, Brazil.
    Borges MLRDR; Souza JLC; Rodrigues LH; Cornélio MTMN; Anjos ACD; Santos N; Salles TJM
    Hematol Transfus Cell Ther; 2024; 46(2):113-118. PubMed ID: 36759292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fanconi anemia neuroinflammatory syndrome: brain lesions and neurologic injury in Fanconi anemia.
    Bartlett AL; Wagner JE; Jones B; Wells S; Sabulski A; Fuller C; Davies SM
    Blood Adv; 2024 Jun; 8(12):3027-3037. PubMed ID: 38522093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An experience with 124 cases of fanconi anemia: clinical spectrum, hematological parameters and chromosomal breakage analysis.
    Mahmood R; Mahmood A; Khan SA; Jaffar R
    Am J Blood Res; 2021; 11(5):498-503. PubMed ID: 34824882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular pathogenesis and clinical management of Fanconi anemia.
    Kee Y; D'Andrea AD
    J Clin Invest; 2012 Nov; 122(11):3799-806. PubMed ID: 23114602
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Review of Fanconi Anemia for the Practicing Pediatrician.
    Triemstra J; Pham A; Rhodes L; Waggoner DJ; Onel K
    Pediatr Ann; 2015 Oct; 44(10):444-5, 448, 450 passim. PubMed ID: 26473424
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anesthetic Management of a Patient With Fanconi Anemia.
    Nagano S; Tsukamoto M; Yokoyama T
    Anesth Prog; 2019; 66(4):218-220. PubMed ID: 31891293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cancer in Fanconi anemia.
    Alter BP; Greene MH; Velazquez I; Rosenberg PS
    Blood; 2003 Mar; 101(5):2072. PubMed ID: 12584146
    [No Abstract]   [Full Text] [Related]  

  • 76. Somatic mosaicism in patients with Fanconi anaemia: Proposal of alternative tissue for inconclusive diagnoses.
    Oliveira Pereira C; Pillonetto DV; Borgonovo T; Rebelatto CLK; Barbosa ML; Finger MC; Nichele S; Trennepohl J; Loth G; Bonfim C
    Int J Lab Hematol; 2022 Oct; 44(5):900-906. PubMed ID: 35644995
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Late-onset Fanconi anemia in an African-Caribbean patient.
    Alfred R; Buchner-Daley L; Soyibo A; Brady-West D; Hardie R; McGrowder D
    J Natl Med Assoc; 2010 Feb; 102(2):132-4. PubMed ID: 20191926
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Individualized risks of first adverse events in patients with Fanconi anemia.
    Rosenberg PS; Huang Y; Alter BP
    Blood; 2004 Jul; 104(2):350-5. PubMed ID: 15059844
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench.
    Wu ZH
    Transl Pediatr; 2013 Jul; 2(3):112-9. PubMed ID: 26835301
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nursing diagnosis after hematopoietic stem cell transplant due to Fanconi anemia.
    Sandri LCS; Pontes L; Bonfim CMS; Kusma SZ
    Rev Bras Enferm; 2021; 75(3):e20190864. PubMed ID: 34852115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.